Acquiring Vega Therapeutics, an offshoot of "hub-and-spoke" biotech Star Therapeutics, would give Incyte a medicine that’s in ...

Noncancerous blood disorders are conditions that affect blood cells, such as red blood cells, white blood cells, and platelets. Blood disorders may cause symptoms and complications, but most are ...

Blood disorders affect millions of people worldwide, yet their potential to develop into blood cancers often goes unrecognized. Medical experts emphasize that understanding this connection plays a ...

A single one-time gene therapy could free patients with α-thalassemia, a rare and debilitating blood disorder, from the burden of lifelong transfusions. A single one-time gene therapy could free ...

What if we could repair fundamental parts of our bodies? Gene therapy promises just that. It's like having a molecular mechanic that can fix or replace faulty genes, potentially curing diseases ...

Lauren Zeller has a one-in-a-million bleeding disorder, but strangers' blood donations give her a chance to play like other ...

Incyte Corp. ( INCY) is close to acquiring privately held Star Therapeutics in a deal valued at up to $2 billion, the ...

Blood disorders known as myelodysplastic syndromes/neoplasms (MDS) are difficult to diagnose—and are commonly misdiagnosed—putting patients at increased risk for treatment mistakes and other ...

In what sounds like a horror movie, an 11-year-old Indian boy began inexplicably bleeding out of his eyes, nose and ears.

Many people avoid blood donation due to myths. An expert explains the facts behind five common misconceptions and why ...

Uttar Pradesh launches PGICH Hemo-GRAM 2026 to enhance diagnosis and treatment of children's blood disorders, improving care ...